Zydus launches biosimilar for ophthalmic care

, the country's first indigenously developed biosimilar of With this launch, the company reinforces its commitment to advancing Currently, more than 100 million people in India are living with diabetes, making it one of the largest diabetic populations globally. "We are committed to making advanced biologics accessible to patients who need them most. ANYRA is a transformative step for affordable retinal care in India. By delivering a high-quality, indigenously developed Aflibercept 2 mg, we are expanding ...